Aging: changes in a passive-avoidance response with brain levels of temazepam.

Area of Science:

• Neuroscience
• Pharmacology
• Gerontology

Background:

• Benzodiazepines like temazepam are widely used for anxiety and insomnia.
• Age can significantly alter drug responses, affecting efficacy and side effects.
• Understanding age-related differences in temazepam's effects is crucial for safe and effective clinical use.

Purpose of the Study:

• To investigate the age-dependent effects of acute intravenous temazepam on passive-avoidance learning in Fischer 344 rats.
• To compare the cognitive impairment induced by temazepam across different age groups: young, mature, and old.
• To explore potential pharmacokinetic and pharmacodynamic factors contributing to age-related differences in temazepam sensitivity.

Main Methods:

• Acute intravenous injections of temazepam were administered to male Fischer 344 rats of three age groups (young, mature, old).
• Performance in the step-down passive-avoidance task was assessed to measure cognitive impairment.
• Brain temazepam levels were measured over time following specific intravenous doses to analyze pharmacokinetic profiles.

Main Results:

• Temazepam's effect on passive-avoidance performance exhibited a U-shaped function of age, impairing young and old rats more than mature rats.
• Mature rats showed no significant impairment even at high temazepam doses (18-320 µg/kg).
• Older rats had higher brain temazepam exposure than mature rats, suggesting pharmacokinetic involvement in increased sensitivity.

Conclusions:

• Mature rats display decreased sensitivity to temazepam's cognitive impairing effects compared to young and senescent rats.
• Age-related pharmacokinetic changes, specifically altered brain temazepam levels, may contribute to increased sensitivity in senescent rats.
• Pharmacodynamic alterations in mature rats might also explain their reduced susceptibility to temazepam-induced cognitive deficits.